AI designs antibiotics for gonorrhea, MRSA
- MIT researchers and collaborators reported in Cell that generative AI produced new antibiotic candidates against drug-resistant gonorrhea and methicillin-resistant Staphylococcus aureus, or MRSA. - The team generated more than 36 million molecules, synthesized 24, and found lead compounds NG1 and DN1 with activity in lab tests and mice. - The work targets pathogens with fast-rising resistance and few new drugs in decades. (mit.edu)
Antibiotics are chemicals that kill bacteria, but most modern searches start with known molecules and tweak them. MIT researchers said generative AI can start from scratch instead. (mit.edu) (cell.com) In a paper published August 14, 2025, in Cell, the team reported AI-designed compounds against drug-resistant Neisseria gonorrhoeae, which causes gonorrhea, and methicillin-resistant Staphylococcus aureus, or MRSA. James Collins of MIT was the senior author. (mit.edu) (broadinstitute.org) The system generated more than 36 million possible molecules and screened them on computers for antibacterial activity before chemists narrowed the list for synthesis and testing. The collaborators ultimately synthesized 24 compounds. (mit.edu) (biopharmatrend.com) Two lead molecules, called NG1 and DN1, emerged from that process. MIT said NG1 showed activity against multidrug-resistant gonorrhea, while DN1 showed activity against both multidrug-resistant gonorrhea and MRSA. (biopharmatrend.com) (cell.com) The paper said the lead compounds were structurally distinct from existing antibiotics and appeared to kill bacteria by disrupting cell membranes. That is a different route than simply modifying an older drug scaffold. (mit.edu) (broadinstitute.org) Cell’s abstract said the compounds showed in vivo efficacy, meaning they worked in animal tests rather than only in a dish. A Cell Host & Microbe commentary identified NG1 and DN1 as leads with potent in vivo activity against multidrug-resistant N. gonorrhoeae and MRSA. (cell.com 1) (cell.com 2) The backdrop is a shrinking antibiotic pipeline. MIT said only a few dozen new antibiotics have been approved by the Food and Drug Administration over roughly 45 years, and most were variants of older drugs. (mit.edu) Gonorrhea is one of the infections that keeps outrunning treatment. The Centers for Disease Control and Prevention says drug-resistant gonorrhea is an urgent public health threat in the United States, and the World Health Organization estimated 82 million new gonorrhea cases worldwide in 2020. (cdc.gov) (who.int) Antimicrobial resistance is already linked to a huge death toll. The World Health Organization says bacterial resistance directly caused 1.27 million deaths in 2019 and was associated with 4.95 million deaths that year. (who.int) Collins said the project lets researchers search chemical territory that standard libraries do not cover. The next step is the old-fashioned part of drug discovery: more chemistry, more safety work, and much more testing before any human use. (mit.edu)
